Research on Biomarkers for Cardiometabolic Risk in Metabolic Syndrome

Dear Colleagues,

Metabolic syndrome (MS) is a complex of specific risk factors related to the development of cardiovascular diseases and diabetes mellitus type 2. The definition of MS includes abdominal obesity, insulin resistance, dyslipidemia, and elevated blood pressure. They are associated with various other disturbances such as a prothrombotic condition, chronic low-grade inflammation, non-alcoholic liver steatosis, obstructive sleep apnea, reproductive disorders, etc. The distribution of metabolic syndrome has been increasing in the past 20 years. It turned into an epidemic in developed and developing countries, making it a medical problem with the growing importance of social impact.

A comprehensive approach that influences the main components of MS is essential, especially in high-risk patients, to normalize the primary metabolic abnormalities, which will reduce the cardiovascular risk and the risk of DM2 in the long term. Recently, more and more attention has been directed to personalized medicine and an individualized approach not only in relation to therapeutic but also to preventive interventions aimed at influencing risk factors and reducing long-term complications. The personalized approach is based on the individual characteristics of individual patients, including different biomarkers and genetic variants. This Special Issue aims to collect research articles and review exploring biomarkers associated with cardiometabolic risk in individuals with metabolic syndrome, with a focus on identifying novel markers and elucidating their role in disease pathogenesis and prevention.

Dr. Antoaneta Trifonova Gateva
Dr. Yavor Sashov Assyov
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• metabolic syndrome
• vascular complications
• biomarkers
• carbohydrate disturbances
• diabetes
• pre-diabetes